Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The identifier ENSG00000304760 appears to refer to a putative or computationally predicted antisense transcript oriented opposite the CDC40 gene, but there is no evidence this represents a functionally validated or pharmacologically relevant target. No information is available in major functional genomics databases for this ID. It is likely a placeholder for an uncharacterized or unreviewed transcript and not an an established therapeutic target[1]. There is likely a problem with this target name or ID: either it is an outdated, incorrect, or non-standard identifier, or it refers to a non-coding RNA/transcript of unknown or unverified function, and thus is not currently considered a therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on novel transcript, antisense to CDC40.